Less radiation better for HPV/oropharynx cancer patients?
Researchers have completed a phase II clinical trial that may help identify patients with human papillomavirus (HPV)-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of intensity-modulated radiation therapy. Preliminary findings will be presented by lead study author Shanthi Marur, MD, an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the American Society of Clinical Oncology (ASCO) annual meeting on

